Internal Medicine, Hematology & Oncology · Stockton, CA
NPI
1104057827
Since 2009
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
7373 West Ln
Stockton, CA, 95210
Phone (209) 476-5778
Groups this clinician bills Medicare through
Medicare paid, 2024
$206K
10,680 services
Medicare patients, 2024
13
Average age 69
Drug cost, 2024
$6.2M
1,838 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Chun F Ng prescribed most often to Medicare patients was Dexamethasone, with 89 prescriptions and refills. In total Chun F Ng wrote 1,838 Medicare prescriptions that cost $6.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-11.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Dexamethasone Generic | 89 | 111 | 55 | $1,943 |
| Ondansetron Hcl Generic | 88 | 88 | 50 | $1,213 |
| Levothyroxine Sodium Generic | 77 | 239 | 25 | $1,401 |
| Tagrisso Osimertinib Mesylate | 69 | 69 | 11 | $1.2M |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 68 | 68 | 27 | $6,730 |
| Hydroxyurea Generic | 56 | 174 | 17 | $2,468 |
| Prednisone Generic | 51 | 92 | 30 | $520 |
| Olanzapine Generic | 45 | 62 | 33 | $340 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 45 | 47 | 31 | $773 |
| Alvaiz Eltrombopag Choline | 44 | 44 | Under 11 | $325K |
| Ibrance Palbociclib | 37 | 37 | Under 11 | $572K |
| Lorazepam Generic | 35 | 35 | 19 | $467 |
| Pomalyst Pomalidomide | 35 | 35 | Under 11 | $852K |
| Anastrozole Generic | 34 | 102 | 17 | $953 |
| Oxycodone Hcl Generic | 29 | 29 | 11 | $781 |
Brand drugs: - claims; generic drugs: 1,369 claims; opioid claims: 163.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Chun F Ng were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.